NEXIMMUNE, INC. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • June 17th, 2022 • NexImmune, Inc. • Pharmaceutical preparations • New York
NexImmune, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. and BTIG, LLC (each individually an “Agent”, and collectively, the “Agents”), as follows:
